Genmab | GEN - Trade Creditors


Genmab reported DKK6M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Agios Pharmaceuticals USD 13.75M 4.61M Mar/2026
Almirall EUR 258.05M 58.66M Dec/2025
Amarin USD 48.15M 2.8M Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
argenx SE USD 554.27M 297.94M Dec/2025
AstraZeneca USD 22.51B 2.78B Mar/2026
Bayer EUR 6.59B 496M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Demant DKK 923M 41M Dec/2025
Exelixis USD 24.15M 5.47M Mar/2026
Fresenius Medical Care EUR 890.43M 54.88M Mar/2026
Genmab DKK 6M 2M Sep/2025
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
GN Store Nord DKK 1.01B 486M Mar/2026
GRIFOLS EUR 841M 37.68M Dec/2025
Hikma Pharmaceutical USD 715M 104M Dec/2025
Insmed USD 73.38M 6.53M Mar/2026
Lakefront Biotherapeutics EUR 95.77M 8.88M Mar/2026
Lonza CHF 471M 3M Dec/2024
Merck EUR 2.13B 19M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.71B 219M Mar/2026
UCB EUR 4.04B 755M Dec/2025